BSE filing, NSE: TATACONSUM. Summary written from the filing by ALFA Finder's alert engine.
Tata Consumer Products Ltd: key numbers
- Share price
- ₹1,000.20
- Market cap
- ₹98,990 Cr
- Revenue (annual)
- ₹20,290 Cr
- Net profit (annual)
- ₹1,542 Cr
- P/E (TTM)
- 58.2×Sector 26.2×
- Promoter holding
- 33.83%+0.00% QoQ
- FII holding
- 19.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Consumer Products Ltd
All →Tata Consumer Products Earnings Call Transcript: Key Takeaways
Tata Consumer delivered strong 14% revenue growth led by Salt and growth businesses, despite tea volume stagnation.
Tata Consumer Products Management Change
Tata Consumer appoints Sunil Lobo as President and Head of India Sales effective December 1, 2026. Mahesh Israni retires January 31, 2027.
Tata Consumer Products Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹5,661 Cr (+14%), EBITDA ₹794 Cr (+18%, margin 14.0%, +40bps), PAT ₹470 Cr (+16%). Growth businesses lead; India tea weak.
Tata Consumer Products Results Update
Tata Consumer reported Q2 revenue up 14% to Rs 5,661 Crore and EBITDA up 18%. Group net profit rose 16% to Rs 470 Crore in the quarter.
Tata Consumer Products Q2 FY27 Results: Net Profit ₹470.1 Cr, Up 15.6% YoY
Tata Consumer Products Ltd reported revenue from operations of ₹5,661 Cr (+14.0% YoY) and net profit of ₹470.1 Cr (+15.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹470.1 Cr · +15.6% YoY
Tata Consumer Products Board Meeting Date
Tata Consumer Products will hold a board meeting on October 26, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date